New research analyzing breast cancer mortality data spanning almost 40 years concludes that breast cancer screening does not yet show an effect on mortality statistics. The research, published in the Journal of the Royal Society of Medicine, analyzed mortality trends before and after the introduction of the National Health Service Breast Screening Programme in 1988.
Researchers at Sandia National Laboratories have confirmed the particle-by-particle mechanism by which lithium ions move in and out of electrodes made of lithium iron phosphate (LiFePO4, or LFP), findings that could lead to better performance in lithium-ion batteries in electric vehicles, medical equipment and aircraft.
Chemists at the University of Pittsburgh have demonstrated a sensor technology that could significantly simplify the diagnosis and monitoring of diabetes through breath analysis alone. Their findings were published in the latest issue of the Journal of the American Chemical Society (JACS).
New technology under development at The Ohio State University is paving the way for low-cost electronic devices that work in direct contact with living tissue inside the body. The first planned use of the technology is a sensor that will detect the very early stages of organ transplant rejection.
A study examining trends in X-ray computed tomography (CT) use in children in the United States has found that reducing unnecessary scans and lowering the doses for the highest-dose scans could lower the overall lifetime risk of future imaging-related cancers by 62 percent. The research by a UC Davis Health System scientist is published online today in JAMA Pediatrics.
Abbott Initiates Randomized Clinical Trial in Japan to Evaluate the AbsorbT Bioresorbable Vascular ScaffoldJune 11, 2013 9:30 am | by The Associated Press | News | Comments
Abbott (NYSE: ABT) today announced that it has initiated the ABSORB Japan randomized controlled clinical trial to evaluate the AbsorbT Bioresorbable Vascular Scaffold (BVS) in patients with coronary artery disease (CAD), the most common form of heart disease.
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today first implantations of a new hip replacement system designed to preserve a key portion of patients’ bone in total hip arthroplasty procedures.
With profit models under pressure and an eroding customer value proposition, medical equipment organizations are at the crossroads of a highly disruptive market. For U.S. companies already sorting through the impact of the medical device excise tax, which led many organizations to downsize and restructure, they still must face significant disruptors on the horizon, with investment dollars flowing in the opposite direction.
Medical products may contain hazardous materials (HAZMAT) that are regulated under the Code of Federal Regulations (CFR). The packaging systems may also be subject to several shipping rules and requirements from the U.S. Department of Transportation (DOT), which follows the United Nations (UN) guidelines. Westpak, Inc., is expanding their HAZMAT testing capacity in response to these growing needs.
Measurement Specialties (MEAS) now offers a 3-channel DC differential amplifier with an exceptionally low noise input of less than 20 µVrms. The new Model 121 enables precision measurement on up to three channels simultaneously. Offering programmable gain up to 9,999 and user-defined output scaling...
The Vortex1 from Farsens S.L. is a battery free RFID sensor tag capable of transmitting a unique identifier and the associated pressure data to a commercial EPC C1G2 reader without the need of a battery on the sensor tag. The device features a LPS331AP pressure sensor from ST Microelectronics with an absolute pressure range from 260 to 1260 mbar.
Colder Products Company has announced the addition of PVDF to the available material options throughout its FitQuik Connectors product line. This material addition creates more than 100 new FitQuik Connectors alongside the existing nylon, polypropylene and polycarbonate materials and configurations available.
A new family of LED-curable needle-bonding adhesives from Dymax has been formulated to cure at speeds typically associated with today’s best automation equipment and line speeds. Typical cure time for the 1400 series is 2.5 seconds or less, allowing for increased production speed and throughput, lower processing costs...
Teleflex Incorporated (NYSE:TFX), a leading global provider of medical devices for critical care and surgery, has announced it has received FDA 510(k) clearance to market its ARROW® NextStep® Retrograde Femoral Length Dialysis Catheters. Designed for clinician ease of insertion and sustained high flow rates, the ARROW NextStep Retrograde Femoral Length Catheters further strengthen the NextStep Hemodialysis Catheter portfolio.
Scott Fallon, formerly the general manager of Global Specialty Products for SABIC’S Innovative Plastics business, was a part of the staff written article, “Materials Impact Medical Device Design Trends.” He took time to present a full array of responses that were not able to be included in the article, so they are presented here.